Redefining Neuroimaging for Therapeutic Innovation —
End-to-End Imaging CRO Services for Clinical Trials
At ZRO Imaging (ZRO), we deliver precise, reliable neuroimaging to accelerate clinical trials in neurodegenerative disease. We partner with biopharma and diagnostics companies to provide expert-driven trial design, advanced PET/MRI analytics, and tailored imaging solutions—reducing risk, saving time, and speeding decisions.
We don’t just support trials—we move them forward. ZRO stands for more than our name. It’s our commitment: zero delays, zero unnecessary complexity—and a future with zero neurodegenerative diseases.
ZRO Imaging — End-to-End Imaging CRO Services
ZRO delivers end-to-end imaging CRO services for clinical trials across multiple therapeutic areas. We help sponsors collect, validate, and interpret imaging data with precision—removing delays, reducing risk, and enabling faster, better-informed decisions.
From first scan to final readout, we make imaging a catalyst for speed and clarity—never a source of delay.
Full-Service Clinical Trial Imaging Support — Phase I to III and Beyond
A clinical trial needs more than scans. It needs strong imaging strategies, high-quality imaging data, and rapid delivery of imaging endpoints. That’s what we provide.
We work across all phases of clinical research—Phase I, II, III, and beyond—handling every detail from imaging protocol design and documentation to site setup, image acquisition, and imaging review. Our oversight ensures every scan meets protocol and is ready for central review the first time.
Whether your study is single-site or spans multiple countries, our team keeps it on track, on time, and 21 CFR Part 11 compliant.
Our Imaging Core Lab Services
We provide comprehensive imaging core lab services for clinical trials, covering the entire imaging lifecycle. Each service is designed to keep your trial on track, on time, and on budget.
01
Imaging Protocol Development and Standardisation
Strong imaging begins with a strong plan. We develop imaging protocols tailored to your trial’s endpoints—aligned with regulatory requirements and practical for site execution. Our expertise spans multiple imaging modalities, including MRI, PET, CT, and more, ensuring high-quality data from the outset.
We standardise image acquisition across all clinical sites, reducing variability, speeding analysis, and minimising downstream delays.
02
Imaging Protocol Development and Standardisation
Even the best imaging protocol needs flawless execution. We train all imaging sites to follow procedures accurately—from scanner setup to secure image transfer.
Our project management team stays closely connected with sites, providing real-time support, resolving issues quickly, and ensuring ongoing compliance throughout the trial.
03
Central Image Management and Quantitative Analysis
We store all imaging data in a secure, centralised system—eliminating the risk of lost files or inconsistent datasets.
Our imaging experts apply validated tools to analyse imaging endpoints and extract meaningful insights. Every image is reviewed through a structured quality control process to ensure accuracy, consistency, and regulatory readiness.
04
Support for Exploratory and Biomarker-driven Endpoints
For trials involving novel tracers, exploratory imaging biomarkers, or emerging imaging endpoints, we provide flexible support and scientific guidance. We help manage complexity and maintain high-quality imaging data—so innovation doesn’t come at the expense of execution.
What Sets ZRO Apart?
Many imaging CROs can execute a plan. ZRO helps you shape it—and see it through.
With deep expertise in neurodegenerative disease imaging and endpoint services, we anticipate challenges before they escalate. Our model combines scientific insight, operational agility, and constant communication—delivering quality imaging data that drives confident decision-making.
Choose ZRO Clinical Trial Imaging You Can Trust
Your clinical trial needs clear imaging endpoints, strong site support, and a partner you can rely on. That’s exactly what we offer.
From early-phase imaging studies to late-stage, multi-center clinical trials across diverse therapeutic areas, ZRO delivers high-quality imaging data you can act on with confidence.
FAQs
What therapeutic areas does ZRO support?
We specialise in Alzheimer’s disease and other neurodegenerative disorders, including rare 4R tauopathies (PSP, CBD) and alpha-synucleinopathies (Parkinson’s disease, multiple system atrophy). We also support other dementia syndromes such as Lewy body dementia and frontotemporal lobar degeneration.
How do you handle image acquisition across different sites?
We work closely with all clinical sites to ensure every image is acquired according to protocol. Our team provides site training, verifies scanner settings, and monitors uploads in real time—delivering immediate feedback to maintain consistent, high-quality imaging data.
Can ZRO support exploratory endpoints?
Yes. We support both standard and exploratory imaging endpoints, with extensive experience in novel tracers and early-phase clinical imaging research.
What imaging modalities do you work with?
We support MRI, PET, CT, and SPECT—applying each modality with trial-specific imaging protocols to ensure consistent, actionable results.
How do you manage imaging data during a trial?
We collect and manage all imaging data in a secure, centralised system—ensuring data integrity, quality control, and 21 CFR Part 11 compliance from start to finish.
For any questions, collaboration opportunities, or additional information, feel free to get in touch. Our team is here to help and will get back to you as quickly as possible.
General inquiries
hello@zroimaging.com
For any questions, collaboration opportunities, or additional information, feel free to get in touch. Our team is here to help and will get back to you as quickly as possible.
General inquiries
hello@zroimaging.com